Information  X 
Enter a valid email address

Ovum plc (OVU)

  Print      Mail a friend

Friday 10 March, 2006

Ovum plc

Admission to AIM

Ovum plc
10 March 2006

10 March 2006

                        Ovum shares commence trading on
                          AIM following successful IPO

Ovum plc ('Ovum' or the 'Company') (OVM.L), the leading provider of research,
advisory and consulting services on and to the global Information, Communication
and Technology (ICT) sectors, today sees its shares commence trading on AIM
following the successful institutional share placing of £10.2 million, of which
£7 million is new money (before expenses) for the Company to facilitate its
strategy of growth through new product development and acquisition.

On Admission, Ovum will have 12,099,710 shares in issue, giving it a market
capitalisation of approximately £23 million at the placing price of 190 pence
per share.

Bridgewell Securities Limited is acting as Nominated Adviser and stockbroker to

Commenting on the successful placing, Chris Dines, Chief Executive of Ovum said:

'Ovum is one of the few global advisory businesses offering expertise across a
broad range of the ICT market. We are delighted by the positive response we have
received from investors to our business. Flotation marks an important step in
the continued development of Ovum and we look forward to building our business
and expanding our product offering around the world, both organically, and by



Ovum                                                               020 7551 9238
Chris Dines, Chief Executive

Bridgewell Securities Limited                                      020 7003 3000
Shaun Dobson / Nick Lovering

Hogarth Partnership                                                020 7357 9477
James Longfield / Barnaby Fry / Georgina Briscoe

Copies of the AIM Admission Document are available during normal business hours
on any weekday (except Saturdays, Sundays and public holidays) free of charge
from the Company on request to Tom Carless, Finance Director, Ovum plc, Cardinal
Tower, 12 Farringdon Road, London, EC1M 3HS, and shall remain so available for
at least one month after Admission

                                    - ENDS -

The Company accepts responsibility for the information contained in this
announcement. To the best of the knowledge and belief of the Company (who has
taken all reasonable care to ensure that such is the case) the information
contained in this announcement is in accordance with the facts and does not omit
anything likely to affect the import of such information.

Bridgewell Securities Limited, which is authorised and regulated in the United
Kingdom by the Financial Services Authority, is acting exclusively for Ovum in
connection with the flotation and no-one else. Bridgewell Securities Limited
will not be responsible for providing advice to any person in relation to the
flotation and/or the associated share offer, the contents of this announcement
or any other matter referred to herein.

The ordinary shares which are proposed to be offered (the 'Ordinary Shares')
have not been, nor will they be, registered under the United States Securities
Act of 1933 (as amended) (the 'Securities Act') and may not be offered or sold,
directly or indirectly, in or into the United States absent registration or an
exemption from registration. There will be no public offer of securities in the
United States.

This announcement does not constitute an offer of, or the solicitation of any
offer to subscribe for or buy, any of the ordinary shares to any person in any
jurisdiction to whom or in which such offer or solicitation is unlawful. The
distribution of this announcement in certain jurisdictions may be restricted by
law and therefore persons into whose possession this announcement comes should
inform themselves about and observe any such restrictions. Any failure to comply
with these restrictions may constitute a violation of the securities laws of
such jurisdiction. The value of shares can go down as well as up. Past
performance is not a guide to future performance. Potential investors should
consult a professional adviser as to the suitability of an investment in the
shares of Ovum for the individual concerned.

                      This information is provided by RNS
            The company news service from the London Stock Exchange

a d v e r t i s e m e n t